Tech funds are hemorrhaging cash: Sell this stock now

Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies.

You can watch for it for free, right here.

Christopher R. Loose net worth and biography

Christopher Loose Biography and Net Worth

Insider of Frequency Therapeutics

Chris has served as Frequency’s Chief Scientific Officer since co-founding the company in 2014. Before joining Frequency, he served as Chief Technology Officer for Semprus BioSciences, a company he also co-founded and was acquired by Teleflex in 2012. During his tenure at Semprus, he led the technology team in developing medical products with surface modifications designed to reduce infection and clotting, leading to FDA and European CE marketing clearance.

Prior to Semprus, Chris worked as a chemical engineer at Merck Research Labs. In 2011, Chris was awarded the inaugural Peter Strauss Entrepreneurial Award from the Hertz Foundation. He has also been named to the MIT Technology Review 35, the 35 innovators under 35 most likely to impact technology, and the Boston Business Journal 40 under 40. He is currently the Executive Director of Yale University’s Center for Biomedical and Interventional Technology (CBIT), and Associate Adjunct Professor of Urology in the Yale School of Medicine.

Chris holds a Ph.D. in Chemical Engineering from MIT, where he was a Hertz Fellow and studied under Robert Langer, Sc.D. Previously, he earned a B.S.E in Chemical Engineering summa cum laude from Princeton University.

What is Christopher R. Loose's net worth?: The estimated net worth of Christopher R. Loose is at least $55,021.54 as of July 28th, 2023. Dr. Loose owns 183,650 shares of Frequency Therapeutics stock worth more than $55,022 as of November 16th. This net worth approximation does not reflect any other investments that Dr. Loose may own. Learn More about Christopher R. Loose's net worth.
How do I contact Christopher R. Loose?: The corporate mailing address for Dr. Loose and other Frequency Therapeutics executives is 19 PRESIDENTIAL WAY SUITE 203, WOBURN MA, 01801. Frequency Therapeutics can also be reached via phone at 781-315-4600 and via email at [email protected]. Learn More on Christopher R. Loose's contact information.
Has Christopher R. Loose been buying or selling shares of Frequency Therapeutics?: Christopher R. Loose has not been actively trading shares of Frequency Therapeutics during the last ninety days. Most recently, Christopher R. Loose sold 1,344 shares of the business's stock in a transaction on Friday, July 28th. The shares were sold at an average price of $0.46, for a transaction totalling $618.24. Following the completion of the sale, the insider now directly owns 183,650 shares of the company's stock, valued at $84,479. Learn More on Christopher R. Loose's trading history.
Who are Frequency Therapeutics' active insiders?: Frequency Therapeutics' insider roster includes Carl LeBel (Insider), Christopher Loose (Insider), Quentin McCubbin (Insider), and Peter Pfreundschuh (CFO). Learn More on Frequency Therapeutics' active insiders.

Christopher R. Loose Insider Trading History at Frequency Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/28/2023	Sell	1,344	$0.46	$618.24	183,650
7/26/2023	Sell	1,329	$0.51	$677.79	186,367
7/24/2023	Sell	1,438	$0.54	$776.52	189,086
7/21/2023	Sell	1,333	$0.61	$813.13	190,524
7/19/2023	Sell	1,335	$0.65	$867.75	193,218
7/17/2023	Sell	1,415	$0.67	$948.05	196,037
7/14/2023	Sell	906	$0.59	$534.54	197,452
7/12/2023	Sell	1,335	$0.39	$520.65	199,687
7/10/2023	Sell	1,304	$0.37	$482.48	66,023
7/6/2023	Sell	1,384	$0.34	$470.56	57,758
7/6/2022	Sell	4,415	$1.53	$6,754.95	50,050
2/22/2022	Sell	1,069	$3.53	$3,773.57
2/18/2022	Sell	974	$3.87	$3,769.38
2/3/2021	Sell	10,000	$45.46	$454,600.00
1/27/2021	Sell	8,000	$42.50	$340,000.00	31,782
12/16/2020	Sell	8,000	$38.94	$311,520.00	63,782
12/14/2020	Sell	8,000	$35.00	$280,000.00	63,782
11/9/2020	Sell	8,000	$24.00	$192,000.00	79,782
11/5/2020	Sell	8,000	$23.00	$184,000.00	79,782
10/13/2020	Sell	8,000	$22.00	$176,000.00	87,782
10/8/2020	Sell	24,000	$20.19	$484,560.00	111,782
10/5/2020	Sell	8,000	$18.35	$146,800.00	135,782
10/1/2020	Sell	8,000	$18.84	$150,720.00	135,782
9/23/2020	Sell	4,500	$21.13	$95,085.00	146,412
9/9/2020	Sell	4,500	$18.97	$85,365.00	149,058
8/19/2020	Sell	4,500	$22.97	$103,365.00	152,782
8/5/2020	Sell	4,500	$21.21	$95,445.00	157,340
7/22/2020	Sell	4,500	$21.51	$96,795.00	161,782
7/8/2020	Sell	4,500	$22.32	$100,440.00	167,061
6/24/2020	Sell	4,500	$22.80	$102,600.00	170,782
6/10/2020	Sell	4,500	$19.96	$89,820.00	175,282
5/20/2020	Sell	4,500	$19.02	$85,590.00	189,114
5/6/2020	Sell	4,500	$16.28	$73,260.00	192,336
4/22/2020	Sell	4,500	$14.84	$66,780.00	196,282
4/8/2020	Sell	4,500	$14.99	$67,455.00	200,782

Christopher R. Loose Buying and Selling Activity at Frequency Therapeutics

Frequency Therapeutics Company Overview

Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules to activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIb clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. The company has a license and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, the Massachusetts Institute of Technology, and The Scripps Research Institute. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts.

Today's Range

Now: $0.30

$0.28

$0.32

50 Day Range

MA: $0.58

$0.22

$14.98

2 Week Range

Now: $0.30

$0.18

$16.00

Volume

309,164 shs

Average Volume

822,537 shs

Market Capitalization

$10.94 million

P/E Ratio

N/A

Dividend Yield